CompletedNot Applicable

Patient Intake At the 'MOvement and REhabilitation (MO.RE.)

Italy95 participantsStarted 2022-08-01

Plain-language summary

In recent years, there has been an exponential increase in studies regarding the benefits of physical activity in oncology, with significant results on improving both physical and psychological outcomes. When appropriately dosed, physical activity can help individuals with a history of cancer to cope with pain and Cancer-Related Fatigue, and improve their quality of life, both during and after cancer treatments. Given the incidence and prevalence of cancer, along with the increase in survival due to advancements in cancer care, it is becoming increasingly important to promote an active lifestyle. For this reason, in August 2022, the MOvement and REhabilitation (MO.RE.) clinic was opened by the S.C. of MFR, dedicated to individuals with a history of cancer at any stage of treatment, with the aim of offering consultations with an experienced physiotherapist to personalize a physical activity program that can help regain a good quality of life, return to daily activities, and prevent the onset of other diseases and recurrences. The clinic also provides therapeutic education activities, following WHO guidelines, on proper lifestyle for wellness and secondary prevention. The aim of our study is to retrospectively analyze the patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024, in order to describe and evaluate the appropriateness of access to the clinic, the expressed needs, and some clinical and rehabilitative data."

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of malignant tumor * Access to the MO.RE. clinic for recommendations on exercise/physical activity * Age over 18 years Exclusion Criteria: * Language barrier * Conditions that prevent the individual from performing physical activity independently

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of cancer patients who accessed the MO.RE. service, matching appropriateness criteria

Timeframe: 2 years

Trial details

NCT IDNCT06858241

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Oncologic Complications trials